Acceptance and Examination of Chemical APIs
Tuesday, 25 January 2022 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Procedures for initiating verification and testing of drug registration (Trial) in 2022

On December 20, 2022, the CDE (Center for Drug Evaluation) published (No.54-2021) the trial working
Tuesday, 25 January 2022 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

CDE announces Latest Consultation Arrangements

Considering the current requirements for epidemic prevention and control and the need of innovative drug
Monday, 20 December 2021 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

New drug clinical trial applications 2020 annual report issued

New drug clinical trial applications 2020 annual report was published on November 10, 2021, by
Monday, 20 December 2021 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

China innovative drug approvals – Technical requirements for pre-NDA meetings issued

China innovative drug approvals shall have pre-NDA meetings carried out at the beginning of the